Gores GJ - Search Results

1

Mesothelin as a potential therapeutic target in human cholangiocarcinoma.

Yu L, Feng M, Kim H, Phung Y, Kleiner DE, Gores GJ, Qian M, Wang XW, Ho M. Yu L, et al. Among authors: gores gj. J Cancer. 2010 Oct 1;1:141-9. doi: 10.7150/jca.1.141. J Cancer. 2010. PMID: 20922056 Free PMC article.

2

CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma.

Diggs LP, Ruf B, Ma C, Heinrich B, Cui L, Zhang Q, McVey JC, Wabitsch S, Heinrich S, Rosato U, Lai W, Subramanyam V, Longerich T, Loosen SH, Luedde T, Neumann UP, Desar S, Kleiner D, Gores G, Wang XW, Greten TF. Diggs LP, et al. J Hepatol. 2021 May;74(5):1145-1154. doi: 10.1016/j.jhep.2020.11.037. Epub 2020 Dec 1. J Hepatol. 2021. PMID: 33276030 Free PMC article.

3

Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.

Maeda T, Taguchi K, Aishima S, Shimada M, Hintz D, Larusso N, Gores G, Tsuneyoshi M, Sugimachi K, Wands JR, de la Monte SM. Maeda T, et al. Cancer Detect Prev. 2004;28(5):313-8. doi: 10.1016/j.cdp.2004.06.001. Cancer Detect Prev. 2004. PMID: 15542253

4

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A; OLT for HCC Consensus Group. Clavien PA, et al. Among authors: gores gj. Lancet Oncol. 2012 Jan;13(1):e11-22. doi: 10.1016/S1470-2045(11)70175-9. Epub 2011 Oct 31. Lancet Oncol. 2012. PMID: 22047762 Free PMC article.

5

Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis.

Bangarulingam SY, Bjornsson E, Enders F, Barr Fritcher EG, Gores G, Halling KC, Lindor KD. Bangarulingam SY, et al. Hepatology. 2010 Jan;51(1):174-80. doi: 10.1002/hep.23277. Hepatology. 2010. PMID: 19877179

6

Hail to the chief-Keith Lindor, our new AASLD president.

Shah VH, Gores GJ, LaRusso NF. Shah VH, et al. Among authors: gores gj. Hepatology. 2016 Feb;63(2):357-9. doi: 10.1002/hep.28342. Epub 2015 Dec 18. Hepatology. 2016. PMID: 26566704 No abstract available.

7

Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches.

Breuhahn K, Gores G, Schirmacher P. Breuhahn K, et al. Hepatology. 2011 Jun;53(6):2112-21. doi: 10.1002/hep.24313. Hepatology. 2011. PMID: 21433041 Review.

8

Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol-Associated Hepatitis.

Yang Z, Zhang T, Kusumanchi P, Tang Q, Sun Z, Radaeva S, Peiffer B, Shah VH, Kamath P, Gores GJ, Sanyal A, Chalasani N, Jiang Y, Huda N, Ma J, Liangpunsakul S. Yang Z, et al. Among authors: gores gj. Hepatology. 2021 Nov;74(5):2436-2451. doi: 10.1002/hep.31994. Epub 2021 Jul 26. Hepatology. 2021. PMID: 34096637 Free PMC article.

9

Hilar cholangiocarcinoma.

Clary B, Jarnigan W, Pitt H, Gores G, Busuttil R, Pappas T. Clary B, et al. J Gastrointest Surg. 2004 Mar-Apr;8(3):298-302. doi: 10.1016/j.gassur.2003.12.004. J Gastrointest Surg. 2004. PMID: 15019927

10

Cholangiocarcinoma: preventing invasion as anti-cancer strategy.

Gores GJ. Gores GJ. J Hepatol. 2003 May;38(5):671-3. doi: 10.1016/s0168-8278(03)00125-9. J Hepatol. 2003. PMID: 12713880 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

701 results

Search Page

Filters